Activity Preview

Live

Telepsychiatry's Role in Medication Assisted Treatment

Activity Type:

  • Live Event


Release Date: 1/29/2019

Expiration Date: 2/12/2019

  • AMA PRA Category 1: 1
  • Participation: 1

Register

Overview

This webinar will explore how telepsychiatry can play a critical role in addressing the shortage of psychiatrists available to provide treatment for patients with opioid use disorders. Participants will learn from one of the experts in the field, Dr. Hector Colon-Rivera, regarding how telepsychiatry is being used to address unmet needs in underserved communities. The history of telepsychiatry, state laws, and standards and guidelines will be covered to enhance your understanding of foundational issues to implementing telepsychiatry in your community. Learning more about telepsychiatry could help vastly improve the treatment options for those who have limited access to care. Bridging the gaps in care for patients with opioid use disorders is another step to address the epidemic that is currently plaguing our nation.

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Pricing

This activity is a mechanism to claim credit for attending the live webinar held on 1/29/19. Attendees will need to enter the Group ID code distributed by email following the event to unlock the activity, complete the evaluation, and claim and print a certificate. If you have misplaced your Group ID, please contact pcssmat@psych.org.

Credit must be claimed by 2/12/19. 

Educational Objectives

  • Describe the history and laws surrounding the use of telepsychiatry as a tool to expand health services and expand the treatment of substance use disorder
  • Examine how telepsychiatry has been used to enhance access to care for the treatment of substance use disorder
  • Assess the interplay of policymaking, telepsychiatry, and Medication Assisted Treatment (MAT) in the treatment of substance use disorder

Target Audience

Physicians who have a waiver to treat opioid use disorder in an office-based setting and other interested clinicians. 

Estimated Time to Complete

Estimated Duration: 1 hour
Begin Date: January 29, 2019
End Date: January 29, 2019

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple-choice quiz is provided based on the content. A passing score of 75% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the event date and hours earned. 

Continuing Education Credit

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Faculty

  • Hector Colon-Rivera, M.D., Attending Physician, University of Pittsburgh Medical Center. Reports no financial relationships with commercial interests.

Program Planners

  • John A. Renner, Jr., M.D., Professor of Psychiatry, Boston University School of Medicine; Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stockholder: Johnson & Johnson and General Electric. 
  • Eunice Maize, American Psychiatric Association. Reports no finanical relationships with commercial interests
  • Rachel Trusty, American Psychiatric Association. Reports no finanical relationships with commercial interests
  • Tristan Gorrindo, M.D., American Psychiatric Association, Reports no finanical relationships with commercial interests 

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

  • Flash Player: Adobe Flash Player 10.3+ 
  • Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements:

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
  • Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content

For assistance: Contact pcssmat@psych.org for questions about this course | Contact learningcenter@psych.org for technical assistance

All materials copyright American Psychiatric Association. ©2019

Register